Your browser doesn't support javascript.
loading
Rheumatoid vasculitis: study of 41 cases. / Vasculitis reumatoide: estudio de 41 casos.
Olivé, Alejandro; Riveros, Anne; Juárez, Pablo; Morales-Ivorra, Isabel; Holgado, Susana; Narváez, Javier.
Afiliação
  • Olivé A; Servicio de Reumatología, Hospital Universitari Germans Trias i Pujol, Badalona (Barcelona), España. Electronic address: aolive.germanstrias@gencat.cat.
  • Riveros A; Servicio de Reumatología, Hospital Universitari Germans Trias i Pujol, Badalona (Barcelona), España.
  • Juárez P; Servicio de Reumatología, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat (Barcelona), España.
  • Morales-Ivorra I; Servicio de Reumatología, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat (Barcelona), España.
  • Holgado S; Servicio de Reumatología, Hospital Universitari Germans Trias i Pujol, Badalona (Barcelona), España.
  • Narváez J; Servicio de Reumatología, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat (Barcelona), España.
Med Clin (Barc) ; 155(3): 126-129, 2020 08 14.
Article em En, Es | MEDLINE | ID: mdl-32147187
ABSTRACT

AIM:

To describe the clinical manifestations, evolution and treatment of patients with rheumatoid vasculitis.

METHODS:

Retrospective study (1975-2017) of all patients diagnosed with rheumatoid vasculitis in 2 Rheumatology Services.

RESULTS:

A total of 41 patients were included, 17 (41.5%) males and 24 (58.5%) females; mean age at diagnosis 67 ± 9 years; duration of rheumatoid arthritis 10 ± 8.3 years. Most patients had erosive disease, 33 (80%). Rheumatoid factor and anticitrullinated antibodies were positive in all patients. Constitutional symptoms were present in 30 (73%) patients and extra-articular manifestations in 17 (41%) patients. The clinical manifestations of rheumatoid vasculitis were mainly cutaneous 28 (68%), and polyneuritis 26 (63%). All patients were treated with glucocorticoids. An immunosuppressant was associated in 24 (58.5%) patients. Five (12%) patients were treated with the association of glucocorticoids and a biologic treatment. The mortality after 2years of follow-up was 33%, the most common causes being infection and progression of the vasculitis. The frequency of rheumatoid vasculitis has decreased over the last decade.

CONCLUSION:

The clinical manifestations of rheumatoid vasculitis were similar to previous studies. The frequency of rheumatoid vasculitis seems to decrease. However, the clinical picture and severity remains invariable.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Vasculite / Vasculite Reumatoide Idioma: En / Es Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Vasculite / Vasculite Reumatoide Idioma: En / Es Ano de publicação: 2020 Tipo de documento: Article